Excessive lipid metabolism in T cell senescence and immunosuppression
Excessive lipid metabolism in T cell senescence and immunosuppression
批准号:
10735675
负责人:
Guangyong Peng
金额:
$38.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-03 至 2028-07-31
关键词:
AddressAffectAmplifiersBreast MelanomaCD8-Positive T-LymphocytesCancer PatientCell AgingCell SurvivalCell TherapyDNA DamageDevelopmentDiseaseEnergy MetabolismEnzymesExhibitsFunctional disorderGenerationsHumanImmune System DiseasesImmune responseImmunosuppressionImmunotherapyLipidsMalignant NeoplasmsMediatingMediatorMetabolicMetabolic DiseasesMetabolismModelingMolecularOutcome StudyPD-L1 blockadePhenotypeProcessProliferatingPublic HealthRegulatory T-LymphocyteRejuvenationReproducibilityResearchRoleT cell therapyT-Cell DevelopmentT-LymphocyteT-Lymphocyte SubsetsTestingTreatment EfficacyTumor ImmunityTumor SuppressionTumor-DerivedUp-RegulationWritinganti-PD-L1anti-PD-L1 therapycancer infiltrating T cellscancer therapycancer typecytokineeffector T cellexhaustexhaustionexperimental studyimmune checkpointimmune checkpoint blockadeimprovedin vivolipid metabolismmalignant breast neoplasmmetabolic profilemitochondrial dysfunctionneoplasm immunotherapynovelnovel strategiespreventprogramssenescencetumortumor microenvironment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Current immunotherapies, including immune checkpoint blockage therapy and adoptive T cell therapy, have
resulted in promising results in certain types of cancer patients. However, these immunotherapies have so far
been insufficient to reproducibly eliminate tumors. It is clear that tumor-reactive T cells are suppressed and
dysfunctional in the suppressive tumor microenvironment that is a major obstacle for successful tumor
immunotherapy. Thus, dissecting the distinct mechanisms responsible for T cell dysfunctional states within the
suppressive tumor microenvironment should provide novel avenues for tumor immunotherapy.
We discovered that induction of T cell senescence is an important T cell dysfunctional state and a novel
suppressive mechanism utilized by both human naturally occurring and tumor-derived regulatory T (Treg) cells
in the tumor microenvironment. In fact, significant accumulation of senescent CD8+ T cells has also been found
in the tumor-infiltrating T cells (TILs) from various types of cancer patients. Importantly, we found that these
senescent T cells are functionally suppressive and molecularly distinct from anergic and exhausted T cellsand
that they are a critical mediator and amplifier for immune suppression within the tumor microenvironments.
Therefore, a better understanding of this novel suppressive mechanism and the molecular processes in
responder T cells suppressed by Treg cells is essential for the development of effective strategies to treat
human cancers. Cellular energy metabolism directs T cell survival, proliferation and their specific functions.
Different T cell subsets have different metabolic profiles. We have more recently identified that Treg-induced
senescent T cells exhibit active lipid metabolism, resulting in upregulation of lipid metabolic enzymes and
secretory lipid species, and accumulation of lipid droplets (LDs). The central hypotheses of this proposal are
that: 1) Excessive lipid metabolism is critical for senescence development and immunosuppression of effector
T cells mediated by Treg cells; 2) Senescent and dysfunctional tumor-specific T cells can be rejuvenated via
lipid reprogramming for enhanced anti-tumor immunity. Specific Aim 1 seeks to identify whether the excessive
lipid metabolism is involved in senescence development and immunosuppression of T cells induced by Treg
cells. Specific Aim 2 will explore the novel concept and develop effective strategies to overcome senescent
and exhausted tumor-specific T cells via lipid metabolism reprogramming combined with selective checkpoint
blockage therapy of anti-PDL1 for enhanced anti-tumor efficiency in the adoptive T cell transfer therapy tumor
models. The positive outcome of these studies should lead to novel strategies to reprogram lipid metabolism
and effector functions of tumor-specific T cells for cancer treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic Control of T Cell Senescence in Pathogenesis and Immunotherapy of Alzheimer's Disease
-
批准号:10516392
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2022
-
负责人:Guangyong Peng
-
依托单位:
Metabolic Control of T Cell Senescence in Pathogenesis and Immunotherapy of Alzheimer's Disease
-
批准号:10830669
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2022
-
负责人:Guangyong Peng
-
依托单位:
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
-
批准号:10557127
-
项目类别:
-
资助金额:$40.87万
-
财政年份:2020
-
负责人:Guangyong Peng
-
依托单位:
Metabolic Control of Innate and Adaptive Immunity in Breast Cancer
-
批准号:9885847
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2020
-
负责人:Guangyong Peng
-
依托单位:
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
-
批准号:10361444
-
项目类别:
-
资助金额:$39.82万
-
财政年份:2020
-
负责人:Guangyong Peng
-
依托单位:
Role of Senescent T cells in Alzheimer's Disease
-
批准号:9975395
-
项目类别:
-
资助金额:$28.59万
-
财政年份:2020
-
负责人:Guangyong Peng
-
依托单位:
Metabolic Control of Innate and Adaptive Immunity in Breast Cancer
-
批准号:10341107
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2020
-
负责人:Guangyong Peng
-
依托单位:
Metabolic Control of Innate and Adaptive Immunity in Breast Cancer
-
批准号:10547790
-
项目类别:
-
资助金额:$43.36万
-
财政年份:2020
-
负责人:Guangyong Peng
-
依托单位:
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
-
批准号:9981183
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2020
-
负责人:Guangyong Peng
-
依托单位:
Gamma/Delta Treg Cells and Human Breast Cancer
-
批准号:9024480
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2015
-
负责人:Guangyong Peng
-
依托单位:
Gamma/Delta Treg Cells and Human Breast Cancer
-
批准号:9228982
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2015
-
负责人:Guangyong Peng
-
依托单位:
Commitment and Plasticity of Th17 cells and Tregs in the Tumor Microenvironment
-
批准号:8417641
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2012
-
负责人:Guangyong Peng
-
依托单位:
Commitment and Plasticity of Th17 cells and Tregs in the Tumor Microenvironment
-
批准号:8228859
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2012
-
负责人:Guangyong Peng
-
依托单位:
海外基金